id	sid	eid	entity	type
bptjm-31	1	1	berkeley pharma tech journal	ORG
bptjm-31	2	1	september 12	DATE
bptjm-31	2	2	2022	CARDINAL
bptjm-31	2	3	november 28	DATE
bptjm-31	2	4	2022	CARDINAL
bptjm-31	2	5	december 28	DATE
bptjm-31	2	6	2022	CARDINAL
bptjm-31	2	7	4.0	CARDINAL
bptjm-31	2	8	lbd	ORG
bptjm-31	3	1	lbd	ORG
bptjm-31	4	1	lbd	ORG
bptjm-31	7	1	venkata	PERSON
bptjm-31	7	2	carlota sagarduy	ORG
bptjm-31	7	3	gatik trivedi	PERSON
bptjm-31	7	4	berkeley pharma tech journal	ORG
bptjm-31	7	5	2 1	DATE
bptjm-31	8	1	three	CARDINAL
bptjm-31	9	1	first	ORDINAL
bptjm-31	9	2	lbd	ORG
bptjm-31	10	1	lbd	ORG
bptjm-31	11	1	lbd	ORG
bptjm-31	12	1	lbd	ORG
bptjm-31	13	1	lbd	ORG
bptjm-31	14	1	one	CARDINAL
bptjm-31	14	2	fda	ORG
bptjm-31	16	1	carbamate3	PERSON
bptjm-31	17	1	lbd movement	ORG
bptjm-31	17	2	treatment1,2	GPE
bptjm-31	18	1	brain4	PERSON
bptjm-31	19	1	lbd	ORG
bptjm-31	20	1	up to 80%	PERCENT
bptjm-31	20	2	lbd	ORG
bptjm-31	20	3	diagnosis5	PERSON
bptjm-31	22	1	lbd	ORG
bptjm-31	22	2	over 85%	PERCENT
bptjm-31	22	3	bradykinesia	PERSON
bptjm-31	23	1	lbd	ORG
bptjm-31	23	2	one ages	DATE
bptjm-31	24	1	1,2	CARDINAL
bptjm-31	24	2	lbd	ORG
bptjm-31	24	3	rem	ORG
bptjm-31	24	4	berkeley pharma tech journal	ORG
bptjm-31	24	5	3	CARDINAL
bptjm-31	24	6	difficulties5	GPE
bptjm-31	28	1	lbd	ORG
bptjm-31	28	2	disease5	PERSON
bptjm-31	29	1	delusions6	ORG
bptjm-31	31	1	lbd	ORG
bptjm-31	32	1	daily	DATE
bptjm-31	34	1	altogether7	PERSON
bptjm-31	35	1	lbd	ORG
bptjm-31	35	2	lbd	ORG
bptjm-31	36	1	lbd	ORG
bptjm-31	43	1	lbd	ORG
bptjm-31	43	2	stages2	ORG
bptjm-31	44	1	lbd	ORG
bptjm-31	46	1	berkeley pharma tech journal	ORG
bptjm-31	46	2	4 2	CARDINAL
bptjm-31	47	1	lbd	ORG
bptjm-31	47	2	lbd	ORG
bptjm-31	47	3	lewy body8,9	PERSON
bptjm-31	49	1	1	CARDINAL
bptjm-31	52	1	berkeley pharma tech journal	ORG
bptjm-31	52	2	5	CARDINAL
bptjm-31	52	3	1	CARDINAL
bptjm-31	54	1	76	CARDINAL
bptjm-31	55	1	one	CARDINAL
bptjm-31	56	1	seven	CARDINAL
bptjm-31	57	1	polyubiquitination	ORG
bptjm-31	59	1	three	CARDINAL
bptjm-31	64	1	enzymes33	PERSON
bptjm-31	66	1	berkeley pharma tech journal	ORG
bptjm-31	66	2	6	CARDINAL
bptjm-31	66	3	2	CARDINAL
bptjm-31	67	1	three	CARDINAL
bptjm-31	68	1	msa	ORG
bptjm-31	69	1	lbd	ORG
bptjm-31	70	1	lbd	ORG
bptjm-31	71	1	lbd	ORG
bptjm-31	71	2	functionally8,9	GPE
bptjm-31	72	1	five	CARDINAL
bptjm-31	72	2	510	CARDINAL
bptjm-31	73	1	44	CARDINAL
bptjm-31	73	2	european	NORP
bptjm-31	73	3	17	CARDINAL
bptjm-31	73	4	europe	LOC
bptjm-31	73	5	27	CARDINAL
bptjm-31	73	6	north america	LOC
bptjm-31	74	1	5	CARDINAL
bptjm-31	75	1	5	CARDINAL
bptjm-31	75	2	8,928	CARDINAL
bptjm-31	76	1	berkeley pharma tech journal	ORG
bptjm-31	76	2	7	CARDINAL
bptjm-31	76	3	3	CARDINAL
bptjm-31	77	1	5	CARDINAL
bptjm-31	79	1	diseases11	GPE
bptjm-31	80	1	lewy bodies11	PERSON
bptjm-31	81	1	3	CARDINAL
bptjm-31	82	1	lbd	ORG
bptjm-31	84	1	lbd	ORG
bptjm-31	85	1	lbd	ORG
bptjm-31	85	2	one	CARDINAL
bptjm-31	85	3	lbd	ORG
bptjm-31	86	1	two	CARDINAL
bptjm-31	86	2	one	CARDINAL
bptjm-31	86	3	3	CARDINAL
bptjm-31	86	4	lbd	ORG
bptjm-31	86	5	5	CARDINAL
bptjm-31	87	1	snca	PERSON
bptjm-31	87	2	first	ORDINAL
bptjm-31	88	1	lbd	ORG
bptjm-31	89	1	berkeley pharma tech journal	ORG
bptjm-31	89	2	8	CARDINAL
bptjm-31	89	3	the b-syn	ORG
bptjm-31	90	1	lbd	ORG
bptjm-31	91	1	one	CARDINAL
bptjm-31	93	1	apoeε2	PERSON
bptjm-31	96	1	two	CARDINAL
bptjm-31	96	2	4	CARDINAL
bptjm-31	97	1	first	ORDINAL
bptjm-31	98	1	5	CARDINAL
bptjm-31	101	1	second	ORDINAL
bptjm-31	103	1	two	CARDINAL
bptjm-31	105	1	lbd	ORG
bptjm-31	106	1	berkeley pharma tech journal	ORG
bptjm-31	106	2	9	CARDINAL
bptjm-31	106	3	4	CARDINAL
bptjm-31	109	1	lbd	ORG
bptjm-31	110	1	lbd	ORG
bptjm-31	110	2	5)13	CARDINAL
bptjm-31	115	1	berkeley pharma tech journal	ORG
bptjm-31	115	2	10	CARDINAL
bptjm-31	115	3	5	CARDINAL
bptjm-31	115	4	lbd	ORG
bptjm-31	116	1	lbd	ORG
bptjm-31	119	1	lbd	ORG
bptjm-31	120	1	one	CARDINAL
bptjm-31	124	1	4.	CARDINAL
bptjm-31	124	2	lbd	ORG
bptjm-31	126	1	1	CARDINAL
bptjm-31	126	2	2	CARDINAL
bptjm-31	126	3	berkeley pharma tech journal	ORG
bptjm-31	126	4	11	CARDINAL
bptjm-31	126	5	3	CARDINAL
bptjm-31	126	6	4	CARDINAL
bptjm-31	126	7	5	CARDINAL
bptjm-31	127	1	three	CARDINAL
bptjm-31	131	1	drugs15	GPE
bptjm-31	134	1	amounts15	GPE
bptjm-31	136	1	adhd15	NORP
bptjm-31	137	1	adhd17	ORG
bptjm-31	140	1	lbd	ORG
bptjm-31	142	1	one	CARDINAL
bptjm-31	144	1	berkeley pharma tech journal	ORG
bptjm-31	145	1	12	CARDINAL
bptjm-31	146	1	rivastigmine	NORP
bptjm-31	151	1	more than 100,000	CARDINAL
bptjm-31	151	2	canada	GPE
bptjm-31	151	3	30%	PERCENT
bptjm-31	152	1	well18	ORG
bptjm-31	154	1	murat emre	PERSON
bptjm-31	154	2	istanbul	GPE
bptjm-31	154	3	new england journal	ORG
bptjm-31	154	4	2005	DATE
bptjm-31	155	1	emre	PERSON
bptjm-31	155	2	trial19	PERSON
bptjm-31	157	1	2007	DATE
bptjm-31	159	1	one	CARDINAL
bptjm-31	159	2	emre	PERSON
bptjm-31	161	1	5	CARDINAL
bptjm-31	161	2	lbd	ORG
bptjm-31	161	3	berkeley pharma tech journal	ORG
bptjm-31	161	4	13	CARDINAL
bptjm-31	164	1	two	CARDINAL
bptjm-31	164	2	mirna	PERSON
bptjm-31	165	1	two	CARDINAL
bptjm-31	166	1	pathogenesis20	ORG
bptjm-31	167	1	mirna	PERSON
bptjm-31	168	1	mirna	PERSON
bptjm-31	168	2	microrna	ORG
bptjm-31	169	1	22	CARDINAL
bptjm-31	170	1	mirna	PERSON
bptjm-31	171	1	mirna	PERSON
bptjm-31	171	2	lbd	ORG
bptjm-31	171	3	mirna	PERSON
bptjm-31	172	1	at least 200	CARDINAL
bptjm-31	174	1	diseases21	GPE
bptjm-31	175	1	mirna	PERSON
bptjm-31	175	2	lbd	ORG
bptjm-31	177	1	one	CARDINAL
bptjm-31	178	1	ncrnas	ORG
bptjm-31	183	1	berkeley pharma tech journal	ORG
bptjm-31	183	2	14	CARDINAL
bptjm-31	186	1	6	CARDINAL
bptjm-31	186	2	6.1	CARDINAL
bptjm-31	186	3	lbd	ORG
bptjm-31	187	1	pd	GPE
bptjm-31	192	1	6.2	CARDINAL
bptjm-31	192	2	lbd	ORG
bptjm-31	193	1	lbd.	ORG
bptjm-31	194	1	as much as 29%26	CARDINAL
bptjm-31	195	1	lbd	ORG
bptjm-31	196	1	first	ORDINAL
bptjm-31	198	1	berkeley pharma tech journal	ORG
bptjm-31	198	2	15	CARDINAL
bptjm-31	199	1	roughly 65%	PERCENT
bptjm-31	200	1	60.5%	PERCENT
bptjm-31	201	1	2	CARDINAL
bptjm-31	201	2	25%	PERCENT
bptjm-31	202	1	roughly 25%28	CARDINAL
bptjm-31	203	1	6.3	CARDINAL
bptjm-31	205	1	disease23	ORG
bptjm-31	210	1	one	CARDINAL
bptjm-31	211	1	lbd	ORG
bptjm-31	212	1	lbd	ORG
bptjm-31	213	1	lbd30	PERSON
bptjm-31	214	1	lbd	ORG
bptjm-31	215	1	berkeley pharma tech journal	ORG
bptjm-31	215	2	16	CARDINAL
bptjm-31	216	1	one	CARDINAL
bptjm-31	216	2	lbd	ORG
bptjm-31	219	1	lbd	ORG
bptjm-31	222	1	1	CARDINAL
bptjm-31	222	2	national institute on aging	ORG
bptjm-31	225	1	national institute on	ORG
bptjm-31	226	1	july 29	DATE
bptjm-31	226	2	2021	DATE
bptjm-31	227	1	2	CARDINAL
bptjm-31	228	1	schumacher j	PERSON
bptjm-31	228	2	peraza lr	PERSON
bptjm-31	230	1	2019	CARDINAL
bptjm-31	230	2	142(6):1767-1782	DATE
bptjm-31	231	1	3	CARDINAL
bptjm-31	231	2	food and drug administration	ORG
bptjm-31	232	1	2007	DATE
bptjm-31	233	1	https://www.accessdata.fda.gov/drugsatfda_docs /label/2007/022083lbl.pdf	PERSON
bptjm-31	233	2	4	CARDINAL
bptjm-31	233	3	food and drug administration	ORG
bptjm-31	234	1	2008	DATE
bptjm-31	235	1	5	CARDINAL
bptjm-31	236	1	hansen la	PERSON
bptjm-31	236	2	richard c. hofstetter	PERSON
bptjm-31	236	3	thal lj	PERSON
bptjm-31	236	4	corey-bloom j	PERSON
bptjm-31	236	5	2006;129(3):729-735	ORG
bptjm-31	237	1	6	CARDINAL
bptjm-31	238	1	goldman	ORG
bptjm-31	238	2	jg	PERSON
bptjm-31	238	3	williams-gray	PERSON
bptjm-31	238	4	barker	PERSON
bptjm-31	238	5	je	PERSON
bptjm-31	238	6	galvin, je	ORG
bptjm-31	239	1	mov disord.	PERSON
bptjm-31	239	2	2014;29	CARDINAL
bptjm-31	239	3	608-621	CARDINAL
bptjm-31	240	1	https://doi.org/10.1002/mds.25866 7	DATE
bptjm-31	240	2	walker z	PERSON
bptjm-31	240	3	possin kl	PERSON
bptjm-31	240	4	lancet	ORG
bptjm-31	240	5	2015;386(10004):1683-1697	CARDINAL
bptjm-31	241	1	0140-6736	DATE
bptjm-31	242	1	8	CARDINAL
bptjm-31	243	1	trojanowski j	PERSON
bptjm-31	245	1	5	CARDINAL
bptjm-31	245	2	1998;832–837	CARDINAL
bptjm-31	247	1	beyer k	PERSON
bptjm-31	247	2	ariza a.	PERSON
bptjm-31	248	1	2009	DATE
bptjm-31	248	2	10(3):724-745	CARDINAL
bptjm-31	249	1	10	CARDINAL
bptjm-31	251	1	2021	CARDINAL
bptjm-31	252	1	10.1038	CARDINAL
bptjm-31	253	1	takahashi h	ORG
bptjm-31	253	2	wakabayashi k.	PERSON
bptjm-31	256	1	2001;21:315	CARDINAL
bptjm-31	257	1	03.x 12	DATE
bptjm-31	258	1	beyer k. epigenetics	PERSON
bptjm-31	259	1	j mol sci	PERSON
bptjm-31	260	1	2020;21(13):4718	CARDINAL
bptjm-31	260	2	2020	DATE
bptjm-31	260	3	jul 2	DATE
bptjm-31	262	1	chouliaras l	ORG
bptjm-31	262	2	kumar gs	PERSON
bptjm-31	262	3	thomas aj	PERSON
bptjm-31	262	4	lunnon k	PERSON
bptjm-31	262	5	chinnery pf	PERSON
bptjm-31	262	6	o'brien jt	PERSON
bptjm-31	265	1	13.	CARDINAL
bptjm-31	267	1	doi:10.1016	GPE
bptjm-31	267	2	14	CARDINAL
bptjm-31	268	1	coppedè f.	PERSON
bptjm-31	270	1	berkeley pharma tech journal	ORG
bptjm-31	270	2	17	CARDINAL
bptjm-31	271	1	2014;5:220	CARDINAL
bptjm-31	272	1	2014 jul 14	DATE
bptjm-31	273	1	15	CARDINAL
bptjm-31	274	1	joshi p.	PERSON
bptjm-31	276	1	2013;1(1):8-18	CARDINAL
bptjm-31	276	2	july 25	DATE
bptjm-31	276	3	2022	CARDINAL
bptjm-31	277	1	09/3	CARDINAL
bptjm-31	277	2	16	CARDINAL
bptjm-31	280	1	1994;19(2):180-222	CARDINAL
bptjm-31	281	1	0173(94)90011-6 17	CARDINAL
bptjm-31	282	1	farah mj	PERSON
bptjm-31	284	1	psychol bull	PERSON
bptjm-31	285	1	2011;137(5):717-741	CARDINAL
bptjm-31	286	1	18	CARDINAL
bptjm-31	287	1	tricco ac	PERSON
bptjm-31	289	1	syst	ORG
bptjm-31	289	2	2012;1:31	TIME
bptjm-31	290	1	2012	DATE
bptjm-31	290	2	28	DATE
bptjm-31	292	1	fernandes c.	PERSON
bptjm-31	293	1	lewy 19.	ORG
bptjm-31	294	1	october 23, 2013	DATE
bptjm-31	295	1	july 26	DATE
bptjm-31	295	2	2022	CARDINAL
bptjm-31	296	1	19	CARDINAL
bptjm-31	297	1	0e	CARDINAL
bptjm-31	297	2	20	CARDINAL
bptjm-31	298	1	ayers d	PERSON
bptjm-31	298	2	scerri c. non-coding	PERSON
bptjm-31	300	1	2018;3(4):188-194	CARDINAL
bptjm-31	301	1	2018	DATE
bptjm-31	302	1	doi:10.1016	GPE
bptjm-31	302	2	21	CARDINAL
bptjm-31	303	1	nguyen ld	PERSON
bptjm-31	303	2	chau rk	PERSON
bptjm-31	303	3	krichevsky	PERSON
bptjm-31	306	1	2021;12(12):2005	CARDINAL
bptjm-31	306	2	2021	CARDINAL
bptjm-31	306	3	dec 17	DATE
bptjm-31	308	1	watson cn	PERSON
bptjm-31	308	2	di pietro	PERSON
bptjm-31	310	1	22	CARDINAL
bptjm-31	312	1	2019	CARDINAL
bptjm-31	312	2	26	CARDINAL
bptjm-31	312	3	fgene.2019.00364 23	DATE
bptjm-31	313	1	tanaka	PERSON
bptjm-31	313	2	lewy bodies	ORG
bptjm-31	314	1	plos one	PERSON
bptjm-31	315	1	2016;11(6):e0157053	CARDINAL
bptjm-31	316	1	2016	CARDINAL
bptjm-31	318	1	24	CARDINAL
bptjm-31	319	1	dominguez lj	PERSON
bptjm-31	319	2	m. nutritional prevention	ORG
bptjm-31	320	1	24	CARDINAL
bptjm-31	322	1	2018;89(2):276	CARDINAL
bptjm-31	323	1	2018	DATE
bptjm-31	323	2	abm.v89i2.7401 25	DATE
bptjm-31	323	3	mrak	PERSON
bptjm-31	323	4	md	GPE
bptjm-31	323	5	w. sue t. gri�n wst	PERSON
bptjm-31	325	1	journ neuropath &	ORG
bptjm-31	325	2	neur	ORG
bptjm-31	326	1	2007;66(8):683-686	CARDINAL
bptjm-31	327	1	1 26	DATE
bptjm-31	328	1	brendon p. boot	PERSON
bptjm-31	328	2	carolyn f. orr	PERSON
bptjm-31	328	3	j. eric ahlskog	PERSON
bptjm-31	328	4	tanis j. ferman	PERSON
bptjm-31	328	5	vernon s. pankratz	PERSON
bptjm-31	328	6	dennis w. dickson	PERSON
bptjm-31	328	7	joseph parisi	PERSON
bptjm-31	329	1	jeremiah a. aakre	PERSON
bptjm-31	329	2	yonas e. geda	PERSON
bptjm-31	329	3	david s. knopman	PERSON
bptjm-31	329	4	ronald c. petersen	PERSON
bptjm-31	329	5	bradley f. risk	PERSON
bptjm-31	330	1	boeve neurology	ORG
bptjm-31	331	1	2013	DATE
bptjm-31	331	2	berkeley pharma tech journal	ORG
bptjm-31	331	3	18	CARDINAL
bptjm-31	332	1	wnl.0b013e3182a2cbd1 27	LAW
bptjm-31	333	1	mata	PERSON
bptjm-31	335	1	neurol	GPE
bptjm-31	336	1	2008;65(3):379–382	CARDINAL
bptjm-31	337	1	doi:10.1001	GPE
bptjm-31	337	2	28	CARDINAL
bptjm-31	338	1	gra	ORG
bptjm-31	338	2	ferman tj	PERSON
bptjm-31	338	3	dickson dw	PERSON
bptjm-31	338	4	delucia mw	PERSON
bptjm-31	338	5	crook je	PERSON
bptjm-31	338	6	barker w	PERSON
bptjm-31	340	1	2006	DATE
bptjm-31	340	2	66	CARDINAL
bptjm-31	340	3	12):1949-1950	DATE
bptjm-31	341	1	29	CARDINAL
bptjm-31	342	1	liu w	PERSON
bptjm-31	342	2	meynert	DATE
bptjm-31	344	1	2020;13(6):1612-1613	CARDINAL
bptjm-31	346	1	liang x	PERSON
bptjm-31	346	2	liu k	PERSON
bptjm-31	346	3	guo l.	PERSON
bptjm-31	348	1	2010;74(5):877-879	CARDINAL
bptjm-31	351	1	national institute on	ORG
bptjm-31	352	1	0dendrites	PRODUCT
bptjm-31	352	2	august 26	DATE
bptjm-31	352	3	2022	CARDINAL
bptjm-31	353	1	32	CARDINAL
bptjm-31	357	1	august 26	DATE
bptjm-31	357	2	2022	CARDINAL
bptjm-31	358	1	33	CARDINAL
bptjm-31	360	1	2020;12(3):a033993	CARDINAL
bptjm-31	361	1	2020	DATE
bptjm-31	361	2	mar 2. 33	DATE
bptjm-31	362	1	berkeley pharma tech journal	ORG
bptjm-31	362	2	19	CARDINAL